SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended ...
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...
Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...
While liver stiffness measurement by vibration-controlled transient elastography with a 25 kPa threshold might detect CSPH, the overall low quality of the studies means that these results are not very ...